Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells

Vaccine

Volumn 35, Issue 45, 2017, Pages 6112-6121

  Forero, Adriana ^a   Fenstermacher, Katherine ^b   Wohlgemuth, Nicholas ^b   Nishida, Andrew ^a   Carter, Victoria ^a   Smith, Elise A ^a   Peng, Xinxia ^a   Hayes, Melissa ^b   Francis, Doreen ^c   Treanor, John ^c   Morrison, Juliet ^a   Klein, Sabra L ^b   Lane, Andrew ^d   Katze, Michael G ^a   Pekosz, Andrew ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epithelial cells; Host response; Inflammation; Influenza virus; Interferon; Live attenuated vaccine

Indexed keywords

INFLUENZA VACCINE; INTERFERON; LIVE VACCINE;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CHEMOTAXIS; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLUENZA A (H3N2); INNATE IMMUNITY; MALE; MONONUCLEAR CELL; NOSE EPITHELIUM; PRIORITY JOURNAL; T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS ATTENUATION; VIRUS REPLICATION; WILD TYPE; ANIMAL; CELL LINE; DOG; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H3N2); MDCK CELL LINE; NOSE MUCOSA; VIROLOGY;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL LINE; DOGS; EPITHELIAL CELLS; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LEUKOCYTES, MONONUCLEAR; MADIN DARBY CANINE KIDNEY CELLS; NASAL MUCOSA; T-LYMPHOCYTES; VACCINES, ATTENUATED;

EID: 85029844480     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.09.058     Document Type: Article

References (41)

1. Anders, S., Pyl, P.T., Huber, W., HTSeq–a Python framework to work with high-throughput sequencing data. Bioinformatics 31 (2015), 166–169.
2. Ank, N., Iversen, M.B., Bartholdy, C., Staeheli, P., Hartmann, R., Jensen, U.B., Dagnaes-Hansen, F., Thomsen, A.R., Chen, Z., Haugen, H., Klucher, K., Paludan, S.R., An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol 180 (2008), 2474–2485.
3. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate – a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 57 (1995), 289–300.
4. Chan, W., Zhou, H., Kemble, G., Jin, H., The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature. Virology 380 (2008), 304–311.
5. Chen, G.L., Lamirande, E.W., Jin, H., Kemble, G., Subbarao, K., Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets. Virology 398 (2010), 109–114.
6. Cheng, X., Zengel, J.R., Suguitan, A.L. Jr., Xu, Q., Wang, W., Lin, J., Jin, H., Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets. J Infect Dis 208 (2013), 594–602.
7. Comer, D.M., Elborn, J.S., Ennis, M., Comparison of nasal and bronchial epithelial cells obtained from patients with COPD. PLoS ONE, 7, 2012, e32924.
8. Crotta, S., Davidson, S., Mahlakoiv, T., Desmet, C.J., Buckwalter, M.R., Albert, M.L., Staeheli, P., Wack, A., Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog, 9, 2013, e1003773.
9. Del Giudice, G., Rappuoli, R., Inactivated and adjuvanted influenza vaccines. Curr Top Microbiol Immunol 386 (2015), 151–180.
10. Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., Gingeras, T.R., STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29 (2013), 15–21.
11. Fischer, W.A. 2nd, Chason, K.D., Brighton, M., Jaspers, I., Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures. Vaccine 32 (2014), 1761–1767.
12. Fischer, W.A. 2nd, King, L.S., Lane, A.P., Pekosz, A., Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells. Vaccine 33 (2015), 4495–4504.
13. Forero, A., Tisoncik-Go, J., Watanabe, T., Zhong, G., Hatta, M., Tchitchek, N., Selinger, C., Chang, J., Barker, K., Morrison, J., Berndt, J.D., Moon, R.T., Josset, L., Kawaoka, Y., Katze, M.G., The 1918 influenza virus PB2 protein enhances virulence through the disruption of inflammatory and Wnt-mediated signaling in mice. J Virol 90 (2015), 2240–2253.
14. Foxman, E.F., Storer, J.A., Fitzgerald, M.E., Wasik, B.R., Hou, L., Zhao, H., Turner, P.E., Pyle, A.M., Iwasaki, A., Temperature-dependent innate defense against the common cold virus limits viral replication at warm temperature in mouse airway cells. Proc Natl Acad Sci USA 112 (2015), 827–832.
15. Giovannini-Chami, L., Marcet, B., Moreilhon, C., Chevalier, B., Illie, M.I., Lebrigand, K., Robbe-Sermesant, K., Bourrier, T., Michiels, J.F., Mari, B., Crenesse, D., Hofman, P., de Blic, J., Castillo, L., Albertini, M., Barbry, P., Distinct epithelial gene expression phenotypes in childhood respiratory allergy. Eur Respir J 39 (2012), 1197–1205.
16. Girard, M.P., Cherian, T., Pervikov, Y., Kieny, M.P., A review of vaccine research and development: human acute respiratory infections. Vaccine 23 (2005), 5708–5724.
17. He, X.S., Holmes, T.H., Zhang, C., Mahmood, K., Kemble, G.W., Lewis, D.B., Dekker, C.L., Greenberg, H.B., Arvin, A.M., Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 80 (2006), 11756–11766.
18. Hoffmann, H.H., Schneider, W.M., Rice, C.M., Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol 36 (2015), 124–138.
19. Hoft, D.F., Babusis, E., Worku, S., Spencer, C.T., Lottenbach, K., Truscott, S.M., Abate, G., Sakala, I.G., Edwards, K.M., Creech, C.B., Gerber, M.A., Bernstein, D.I., Newman, F., Graham, I., Anderson, E.L., Belshe, R.B., Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis 204 (2011), 845–853.
20. Ilyushina, N.A., Ikizler, M.R., Kawaoka, Y., Rudenko, L.G., Treanor, J.J., Subbarao, K., Wright, P.F., Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium. J Virol 86 (2012), 11725–11734.
21. Jin, H., Lu, B., Zhou, H., Ma, C., Zhao, J., Yang, C.F., Kemble, G., Greenberg, H., Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology 306 (2003), 18–24.
22. Johnson, W.E., Li, C., Rabinovic, A., Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8 (2007), 118–127.
23. Kumlin, U., Olofsson, S., Dimock, K., Arnberg, N., Sialic acid tissue distribution and influenza virus tropism. Influenza Other Respir Viruses 2 (2008), 147–154.
24. Lalime, E.N., Pekosz, A., The R35 residue of the influenza A virus NS1 protein has minimal effects on nuclear localization but alters virus replication through disrupting protein dimerization. Virology 458–459 (2014), 33–42.
25. Lane, A.P., Saatian, B., Yu, X.Y., Spannhake, E.W., mRNA for genes associated with antigen presentation are expressed by human middle meatal epithelial cells in culture. Laryngoscope 114 (2004), 1827–1832.
26. Langmead, B., Salzberg, S.L., Fast gapped-read alignment with Bowtie 2. Nat Methods 9 (2012), 357–359.
27. Lanthier, P.A., Huston, G.E., Moquin, A., Eaton, S.M., Szaba, F.M., Kummer, L.W., Tighe, M.P., Kohlmeier, J.E., Blair, P.J., Broderick, M., Smiley, S.T., Haynes, L., Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses. Vaccine 29 (2011), 7849–7856.
28. Lau, Y.F., Wright, A.R., Subbarao, K., The contribution of systemic and pulmonary immune effectors to vaccine-induced protection from H5N1 influenza virus infection. J Virol 86 (2012), 5089–5098.
29. McCown, M.F., Pekosz, A., The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging. J Virol 79 (2005), 3595–3605.
30. Nakaya, H.I., Wrammert, J., Lee, E.K., Racioppi, L., Marie-Kunze, S., Haining, W.N., Means, A.R., Kasturi, S.P., Khan, N., Li, G.M., McCausland, M., Kanchan, V., Kokko, K.E., Li, S., Elbein, R., Mehta, A.K., Aderem, A., Subbarao, K., Ahmed, R., Pulendran, B., Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 12 (2011), 786–795.
31. Pyo, H.M., Zhou, Y., Protective efficacy of intranasally administered bivalent live influenza vaccine and immunological mechanisms underlying the protection. Vaccine 32 (2014), 3835–3842.
32. Ramanathan, M. Jr., Lane, A.P., Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis. Otolaryngol Head Neck Surg 136 (2007), 348–356.
33. Ramanathan, M. Jr., Lee, W.K., Dubin, M.G., Lin, S., Spannhake, E.W., Lane, A.P., Sinonasal epithelial cell expression of toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps. Am J Rhinol 21 (2007), 110–116.
34. Reed, L.J.M.H., A simple method of estimating fifty percent endpoints. Am J Hyg 27 (1938), 493–497.
35. Robinson, M.D., McCarthy, D.J., Smyth, G.K., edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26 (2010), 139–140.
36. Sasaki, S., Jaimes, M.C., Holmes, T.H., Dekker, C.L., Mahmood, K., Kemble, G.W., Arvin, A.M., Greenberg, H.B., Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 81 (2007), 215–228.
37. Snyder, M.H., Betts, R.F., DeBorde, D., Tierney, E.L., Clements, M.L., Herrington, D., Sears, S.D., Dolin, R., Maassab, H.F., Murphy, B.R., Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol 62 (1988), 488–495.
38. Snyder, M.H., Clements, M.L., De Borde, D., Maassab, H.F., Murphy, B.R., Attenuation of wild-type human influenza A virus by acquisition of the PA polymerase and matrix protein genes of influenza A/Ann Arbor/6/60 cold-adapted donor virus. J Clin Microbiol 22 (1985), 719–725.
39. Subbramanian, R.A., Basha, S., Shata, M.T., Brady, R.C., Bernstein, D.I., Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination. Vaccine 28 (2010), 8258–8267.
40. Wareing, M.D., Lyon, A.B., Lu, B., Gerard, C., Sarawar, S.R., Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J Leukoc Biol 76 (2004), 886–895.
41. Zhou, Z., Hamming, O.J., Ank, N., Paludan, S.R., Nielsen, A.L., Hartmann, R., Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol 81 (2007), 7749–7758.